The Same Peptide Costs $35 and $135. You're Not Comparing Products, You're Comparing Invoices.

Thirty-five dollars. A hundred and thirty-five.

Same compound name on both labels. Same milligram figure. Same little glass vial with the grey flip cap. You have three tabs open, the prices are four times apart, and nothing on either page explains why. So you do what every new buyer does, which is decide that the cheap one must be fake or the expensive one must be a markup, pick a side, and click.

I sell in this market. I have set prices, I have read other people's certificates at eleven at night, and I have had the same argument with myself that you are having with your browser. Here is what I think you have wrong, and it is not which vial to buy.

You are treating the price as a quality score. It is not a score. It is an invoice with the line items deleted.

A price is seven things stacked on top of each other

When I look at a vial price, I break it into seven parts. I call them the seven line items, and I want to be clear that this is my editorial lens, not an industry standard and not a taxonomy anyone else recognises: material and sequence complexity, synthesis scale, net peptide content versus the weight printed on the label, analytical testing and who performed it, how specific the documentation is, fill and lyophilisation and cold-chain handling, and margin.

Six of those are real work. One is profit. None of them are visible on a product page.

The rule I use is unglamorous. Any line item you cannot verify, score as absent. Not "probably fine." Absent. That rule cuts in both directions, which is the part people hate, because it means a $135 vial with no stated method and a generic certificate scores exactly the same as a $35 vial with no stated method and a generic certificate. You are paying a hundred dollars for the font.

You cannot eyeball a lyophilised peptide. It is a thimble of white fluff that looks identical to every other thimble of white fluff, which is both the whole problem and, for some people, the whole business model.

"99% pure" is a number without a unit

Here is the finding that changed how I read a certificate. In work on radiolabeled somatostatin-analogue preparations, the same samples were followed for four hours by two different analytical techniques. By radio-thin-layer chromatography, a method that separates compounds as they creep up a coated plate, the preparations looked stable. By radio-high-performance liquid chromatography, a method that pushes the sample through a packed column under pressure and generally resolves things more finely, purity drifted down over those same four hours.

Same material. Same clock. Two verdicts.

It is not that one instrument lies. It is that a purity figure is the answer to a question, and if nobody tells you the question, the number is decoration. In that same body of work, four different labeling protocols all came in above 95% mean radiochemical purity when measured by the plate method. Numbers that high are easy to print and hard to interpret without knowing what produced them.

Methods can also agree, which is the encouraging half. Two independent mass-spectrometry approaches to quantifying a protein standard, one counting amino acids and one counting a signature fragment, landed on 0.770 mg/g and 0.769 mg/g with no significant difference between them. That is what it looks like when the work is done properly. The lesson is not "distrust all numbers." It is that a method named next to a number is worth more than a bigger number with nothing attached.

Cheap is sometimes just efficient, and efficiency has a variance bill

I want to be fair to the $35 vial, because the lazy version of this piece is that cheap means fake, and I have no evidence for that. As far as I can find, nobody has published a dataset correlating research-peptide price with measured purity. Not one. Everybody arguing cheap-equals-junk or expensive-equals-verified is reasoning from vibes, and that includes the people reasoning in my favour.

Scale genuinely lowers cost. But look at what happens when you push it. In one radiopharmacy, splitting a single kit into two aliquots doubled the number of preparations they got out of it. Real efficiency, real savings. It also came with more variability: 33% of 94 routine preparations landed between 80% and 95% radiochemical purity rather than above 95%.

That is the honest shape of a discount. Not fraud. Wider spread.

And spread is the thing one certificate cannot cover. When four enrichment methods for bacterial vesicles were compared, the products looked the same by size and appearance, but purity and yield varied between methods and, critically, within the same method run again. A systematic review of 53 mouse-serum studies found that isolation method, extraction protocol, and unreported handling details all fed variability in the results. Unreported. That is the word to sit with. The confounder that moves your batch is usually the one nobody wrote down.

Handling is its own line item too. A certified reference protein held its value for 7 days at minus 20 and 13 months at minus 70. Temperature and time are not shipping theatre. They are a specification.

What I will say about our own paperwork

Our certificates confirm identity by LC-MS and print the mass-confirmation spectra, so identity is established separately from purity rather than folded into it. They report net content per vial, measured on two vials rather than one, against the label weight. They carry a lot identifier with received and reported dates. They name the outside laboratory that ran the analysis.

Now the part I would rather not write. A certificate describes the sample that was tested. It does not guarantee the vial in your hand. That is true of ours. It is true of everyone's, and any supplier who implies otherwise is selling you certainty that chemistry does not offer. We are also auditing every certificate page we publish against the full seven line items, including whether each purity figure states its technique, its detection wavelength, and says plainly when it is area-percent. Anything we cannot demonstrate stays named as a gap until we can.

Notice what good documentation looks like at the top end: a reference material certified at 74.1 ± 3.6 µg/g by three independent approaches. A value, and an uncertainty. Ask yourself when you last saw an uncertainty on a product page.

Four questions, same words, both tabs

Before you compare two prices, send both suppliers the identical message and compare the replies instead:

1. What is the net peptide content, as opposed to the gross fill weight in the vial?
2. What analytical method produced the purity figure, and at what detection setting?
3. Is the certificate lot-specific to the vial I will actually receive?
4. Who ran the test, in-house or a named outside lab?

A $35 vial that answers all four is a better buy than a $135 vial that answers none. A vial that answers none at any price is being sold on trust, and you should price it accordingly.

When labs buy material they intend to rely on, they do not take the label's word for it. A commercially sourced glucagon calibration standard got independently re-characterised by two methods and came back at 1.596 mg/g, because characterising your inputs is what makes results comparable between days and between laboratories. You are doing a smaller version of the same job with four emails.

Read our testing and certificate-of-analysis page to see exactly which of the seven line items we document, which lab performs them, and what our COAs do and do not establish.